Relatlimab and nivolumab: Solution concentrate for I.V. infusion containing 80 mg relatlimab and 240 mg nivolumab in 20 mL vial; Opdualag® - March 2023- July 2023 PBAC meetings Page last updated: 27 October 2023 Public Summary Document (PSD) March 2023 July 2023 PBAC Meetings - (PDF 1.1MB) Public Summary Document (PSD) March 2023 July 2023 PBAC Meetings - (Word 796KB)